Herb-Pharma Corporation s.r.o.

Herb-Pharma Corporation s.r.o. specializes in herbal and botanical topical medical devices. Their portfolio includes products like ear drops, ear sprays, nasal sprays, vaginal suppositories (including probiotic variants), oral pastilles, and ear candles. These devices are designed for conditions such as ear care, nasal congestion, vaginal health, and respiratory support, all under the fytofontana brand.

Herb-Pharma Corporation s.r.o. is based in Slovakia, which is part of the European Union. As an EU-based manufacturer, its devices must comply with EU Medical Device Regulations (MDR) or Medical Device Directives (MDD), depending on the applicable timeline. All relevant products are listed in the EUDAMED database, demonstrating transparency and adherence to EU regulatory requirements for medical devices.

The devices produced by Herb-Pharma Corporation s.r.o. fall under Class I, Class IIa, and Class IIb classifications in the EU regulatory framework. Classification determines the level of scrutiny and regulatory controls required—Class I devices are generally low-risk, while Class IIa and IIb involve higher risks and stricter compliance obligations, such as clinical evaluations or conformity assessments.

Yes, all relevant devices manufactured by Herb-Pharma Corporation s.r.o. are listed in the EUDAMED database. This matters because EUDAMED is the official EU registry for medical devices, ensuring transparency about device manufacturers, their products, and regulatory status. Listing in EUDAMED helps healthcare professionals, regulators, and patients verify the legitimacy and compliance of the devices with EU medical device laws.

The classification of a medical device depends on its intended purpose and potential risks. Class I devices, like some ear drops or nasal sprays, are typically low-risk and pose minimal harm if misused. Class IIa devices, such as certain vaginal suppositories or ear candles, involve moderate risks and may require additional safety measures, such as performance evaluations. Class IIb devices, if applicable, would involve higher risks (e.g., more complex vaginal health products) and require rigorous clinical data or specialized conformity assessments to ensure safety and effectiveness.